These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3873433)
1. Cellular uptake of misonidazole and analogues with acidic or basic functions. Dennis MF; Stratford MR; Wardman P; Watts ME Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):629-43. PubMed ID: 3873433 [TBL] [Abstract][Full Text] [Related]
2. The effect of extracellular pH on radiosensitization by misonidazole and acidic or basic analogues. Watts ME; Jones NR Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):645-53. PubMed ID: 3873434 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the intracellular uptake and radiosensitization efficiency in different media of uncharged 2-nitroimidazoles of varying lipophilicity. Watts ME; Dennis MF; Jones NR; Stratford MR Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Sep; 52(3):359-70. PubMed ID: 3497892 [TBL] [Abstract][Full Text] [Related]
4. Radiosensitization by misonidazole, pimonidazole and azomycin and intracellular uptake in human tumour cell lines. Watts ME; Dennis MF; Roberts IJ Int J Radiat Biol; 1990 Feb; 57(2):361-72. PubMed ID: 1968500 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats. Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852 [TBL] [Abstract][Full Text] [Related]
6. A comparison of tumor and normal tissue levels of acidic, basic and neutral 2-nitroimidazole radiosensitizers in mice. Minchinton AI; Stratford MR Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1117-20. PubMed ID: 2943710 [TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers. Hei TK; Geard CR; Osmak RS; Hall EJ Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777 [TBL] [Abstract][Full Text] [Related]
8. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro. Brown DM; Cohen MS; Sagerman RH; Gonzalez-Mendez R; Hahn GM; Brown JM Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622 [TBL] [Abstract][Full Text] [Related]
9. Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799. Dische S; Saunders MI; Dunphy EP; Bennett MH; Des Rochers C; Stratford MR; Minchinton AI; Orchard RA Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1109-11. PubMed ID: 2943708 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole. White R; Workman P; Owen L Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains. Adams GE; Ahmed I; Clarke ED; O'Neill P; Parrick J; Stratford IJ; Wallace RG; Wardman P; Watts ME Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Dec; 38(6):613-26. PubMed ID: 6970731 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours. Brown JM; Yu NY; Workman P Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione. DeGraff WG; Russo A; Gamson J; Mitchell JB Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917 [TBL] [Abstract][Full Text] [Related]
14. Factors influencing intracellular uptake and radiosensitization by 2-nitroimidazoles in vitro. Brown DM; Gonzalez-Mendez R; Brown JM Radiat Res; 1983 Mar; 93(3):492-505. PubMed ID: 6856754 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799. Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of hypoxic cell radiosensitizers: a review. Workman P Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321 [TBL] [Abstract][Full Text] [Related]
17. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration. Koch CJ; Stobbe CC; Baer KA Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755 [TBL] [Abstract][Full Text] [Related]
18. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069. Walling J; Stratford IJ; Adams GE; Stephens MA Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr; 53(4):641-9. PubMed ID: 3258298 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans. Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201 [TBL] [Abstract][Full Text] [Related]
20. In vivo testing of a 2-nitroimidazole radiosensitizer (Ro 03-8799) using repeated administration. Williams MV; Denekamp J; Minchinton AI; Stratford MR Int J Radiat Oncol Biol Phys; 1982; 8(3-4):477-81. PubMed ID: 7107370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]